Targeted protein degrader technology | A revolutionary approach to drug development 

Targeted protein degradation (TPD) is a cutting edge therapeutic modality with the potential to destroy disease-causing proteins that have historically been undruggable with conventional small molecules.
Unlike conventional drugs that only inhibit the activity of disease-causing proteins, targeted protein degraders completely destroy the protein.
At Ternarx, a WEHI spinout company, researchers are using TPD technology to develop new treatments for cancer and other diseases.
Read more: www.wehi.edu.au/ternarx/

Наука